• Colgate-Palmolive’s Q1 Adjusted EPS surpassed estimates with 86c as compared to a forecast of 82c
• Its net sales stood at $5.07 billion, marking a 6.2% year-on-year increase, topping the estimated $4.95 billion
• The firm saw a 9.8% growth in organic sales, exceeding the 5.06% estimate
• In North America, organic sales were up by 4%, surpassing the 2.81% estimate
• Organic sales in Latin America shot up drastically by 25.9%, a dramatic rise from the estimated 11%
• In contrast, the Asia Pacific region saw a moderate increase of 1.5% in organic sales, lower than the estimated 2.04%
• The Hill’s unit reported a minor increase in organic sales of 4.2%, slightly lower than the estimated 4.62%
• Organic volume growth was 1.3% instead of the forecasted 0.08%
• North America saw a decent organic volume growth of 2.9%, significantly higher than the 0.4% estimate
• The organic volume in Latin America increased by 6.2% as opposed to the estimated 3.58%
• Asia Pacific area had a slower organic volume growth of 2.9% drop, much lesser than the estimated 4% decrease
• Hill’s unit suffered a setback with a 3.9% dip in organic volume, a stark contrast to the forecast of a 0.55% decrease
• There was a drastic 8.5% rise in pricing, surpassing the estimate of a 5.09% increase
• North America had a minor pricing increase of 1.2%, lower than the estimated 2.64%
• Latin America had a surprisingly high pricing increase of 19.7%, far beyond the estimated 7.09%
• Asia Pacific pricing rose by 4.4%, marginally above the 3.75% estimate
• Hill’s unit pricing growth was 8.2%, surpassing the 6.95% estimate
• Based on the above results, the company has updated its financial guidance for the full year 2024
• As it stands, there are 16 buys, 6 holds, and 2 sells for Colgate-Palmolive shares
Colgate Palmolive Co on Smartkarma
Analyst coverage of Colgate Palmolive Co on Smartkarma reveals insights from Baptista Research. In the report titled “Colgate-Palmolive: What Is Its New Approach To Market Expansion & Its New Pricing Strategy? – Major Drivers,” the company’s fourth-quarter earnings showcased resilience in 2023, focusing on sustainable organic sales growth and margin rebuilding. Despite challenges like geopolitical unrest and foreign exchange headwinds, Baptista Research evaluates factors influencing the company’s future price, conducting an independent valuation using a Discounted Cash Flow methodology.
Furthermore, Baptista Research‘s report “Colgate-Palmolive Company: Focus On Science-Based Innovation As A Major Growth Catalyst! – Key Drivers” highlights the company’s positive performance in the last quarter, with a significant operating profit growth and a notable increase in advertising expenditure. The emphasis on science-based innovation as a growth catalyst sets a positive trajectory for volume growth. The report conducts a fundamental analysis of the company’s historical financial statements, providing valuable insights for investors on Colgate Palmolive Co‘s strategic direction and growth potential.
A look at Colgate Palmolive Co Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Colgate-Palmolive Co, a global consumer products company renowned for its extensive range of household and personal care items, holds a mixed outlook based on Smartkarma Smart Scores. With a momentum score of 4, the company shows strong potential for growth and performance in the near future. Its growth and dividend scores of 3 signify a stable trajectory in these crucial areas, indicating a reliable investment option for those seeking long-term returns. However, with value and resilience scores of 2, investors may need to consider potential challenges in terms of valuation and adaptability to market fluctuations.
Colgate-Palmolive Co’s Smartkarma Smart Scores suggest a company with promising momentum and solid growth prospects, underpinned by a consistent track record in providing essential consumer products worldwide. While its overall outlook is positive, investors should carefully evaluate the factors contributing to the scores to make informed decisions regarding their investment strategies in this industry giant.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
